Complete News, Your Way.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Mother's Day
Pope Leo XIV
Artificial Intelligence
Donald Trump
Social Media
Democratic Party
Baseball
Pope Francis
Republican Party
Golf
Trade
US Politics
Published • loading... • Updated

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?

Summary by News Medical
Researchers performed an observational cohort study using the US Department of Veterans Affairs healthcare databases.

2 Articles

All
Left
Center
2
Right
HealthDayHealthDay
Center

Nirmatrelvir Cuts Risk for Post-COVID-19 Condition

MONDAY, March 27, 2023 (HealthDay News) -- Treatment with nirmatrelvir during the acute phase of COVID-19 may reduce the risk for postacute adverse health outcomes, according to a study published online March 23 in JAMA Internal Medicine.

Read Full Article
News MedicalNews Medical
Center

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?

Researchers performed an observational cohort study using the US Department of Veterans Affairs healthcare databases.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

News Medical broke the news in United States on Monday, March 27, 2023.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Coronavirus

Coronavirus

Medical

Medical

Athens, Tennessee

Athens, Tennessee

News
For You
SearchBlindspotLocal